EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Systematic benchmarking of mass spectrometry-based antibody sequencing reveals methodological biases

Maria Chernigovskaya, Khang Lê Quý, Maria Stensland, Sachin Singh, Rowan Nelson, Melih Yilmaz, Konstantinos Kalogeropoulos, Pavel Sinitcyn, Anand Patel, Natalie Castellana, Stefano Bonissone, Stian Foss und 7 weitere

Cell Systems · 2025

DOI: 10.1016/j.cels.2025.101449 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Systems, 2025. Verfasst von Maria Chernigovskaya und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, University of Oslo, Oslo University Hospital, Oslo, Norway. Hauptthemen laut MEDLINE: Benchmarking, Mass Spectrometry, Antibodies. Die Arbeit nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Leona M and Harry B Helmsley Charitable Trust, IMI2.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The circulating antibody (Ab) repertoire is crucial for immune protection, holding significant immunological and biotechnological value. While bottom-up mass spectrometry (MS) is widely used for profiling the sequence diversity of circulating Abs (Ab repertoire sequencing [Ab-seq]), it has not been thoroughly benchmarked. We quantified the replicability and robustness of Ab-seq using six monoclonal Ab spike-ins in 70 combinations of concentration and oligoclonality, with and without polyclonal serum immunoglobulin G (IgG) background. Each combination underwent four protease treatments and was analyzed across four experimental and three technical replicates, totaling 3,360 liquid chromatography-tandem MS (LC-MS/MS) runs. We quantified the dependence of Ab-seq identification on Ab sequence, concentration, protease, presence of background IgGs, and bioinformatics methods. Integrating the data from experimental replicates, proteases, and bioinformatics tools enhanced Ab identification. De novo sequencing performed similarly to database-dependent methods at higher Ab concentrations, but de novo Ab reconstruction remains challenging. Our work provides a foundational resource for the field of MS-based Ab profiling. A record of this paper's transparent peer review process is included in the supplemental information.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenchmarkingMass SpectrometryAntibodiesHumansTandem Mass SpectrometryChromatography, LiquidImmunoglobulin GComputational BiologyAntibodies, Monoclonal

Stichwörter der Autor:innen

Ab-seq, LC-MS/MSantibodybenchmarkingde novo sequencing

Substanzen

Immunoglobulin GAntibodiesAntibodies, Monoclonal

Autor:innen und Institutionen

  • Department of Immunology, University of Oslo, Oslo University Hospital, Oslo, Norway.
  • Proteomics Core Facility, University of Oslo, Oslo University Hospital, Oslo, Norway.
  • University of Washington, Seattle, WA, USA.
  • Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark.
  • Morgridge Institute for Research, Madison, WI, USA; Department of Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands; Department of Information and Computing Sciences, Utrecht University, Utrecht, the…
  • Abterra Biosciences Inc., San Diego, CA, USA.

Förderung

  • NIGMS NIH HHS
  • Leona M and Harry B Helmsley Charitable Trust
  • IMI2
  • The Norwegian Cancer Society
  • Forskningsrådet
  • European Research Council

Zitieren

APA

Chernigovskaya, M., Lê Quý, K., Stensland, M., Singh, S., Nelson, R., Yilmaz, M., Kalogeropoulos, K., Sinitcyn, P., Patel, A., Castellana, N., Bonissone, S., Foss, S., Andersen, J. T., Sandve, G. K., Jenkins, T. P., Noble, W. S., Nyman, T. A., Snapkow, I., & Greiff, V. (2025). Systematic benchmarking of mass spectrometry-based antibody sequencing reveals methodological biases. Cell Systems. https://doi.org/10.1016/j.cels.2025.101449

Vancouver

Chernigovskaya M, Lê Quý K, Stensland M, Singh S, Nelson R, Yilmaz M, et al. Systematic benchmarking of mass spectrometry-based antibody sequencing reveals methodological biases. Cell Systems. 2025. doi:10.1016/j.cels.2025.101449

BibTeX
@article{Chernigovskaya2025,
  author = {Chernigovskaya, Maria and Lê Quý, Khang and Stensland, Maria and Singh, Sachin and Nelson, Rowan and Yilmaz, Melih and Kalogeropoulos, Konstantinos and Sinitcyn, Pavel and Patel, Anand and Castellana, Natalie and Bonissone, Stefano and Foss, Stian and Andersen, Jan Terje and Sandve, Geir Kjetil and Jenkins, Timothy Patrick and Noble, William S and Nyman, Tuula A and Snapkow, Igor and Greiff, Victor},
  title = {Systematic benchmarking of mass spectrometry-based antibody sequencing reveals methodological biases},
  journal = {Cell Systems},
  year = {2025},
  doi = {10.1016/j.cels.2025.101449}
}
Kostenlos starten →